These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30612920)

  • 1. Guillain-Barré Syndrome Related to Nivolumab: Case Report of a Patient With Urothelial Cancer and Review of the Literature.
    Kyriazoglou A; Liontos M; Papadopoulos C; Bilali A; Kostouros E; Pagoni S; Doumas K; Dimopoulos MA; Bamias A
    Clin Genitourin Cancer; 2019 Apr; 17(2):e360-e364. PubMed ID: 30612920
    [No Abstract]   [Full Text] [Related]  

  • 2. Nivolumab-Associated Guillain-Barre Syndrome in a Patient With Non-Small-Cell Lung Cancer.
    Thapa B; Khalid S; Vakili R; Ui J; Misbah S
    Am J Ther; 2018; 25(6):e761-e763. PubMed ID: 29889678
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune Checkpoint Inhibitor-related Guillain-Barré Syndrome: A Case Series and Review of the Literature.
    Janssen JBE; Leow TYS; Herbschleb KH; Gijtenbeek JMM; Boers-Sonderen MJ; Gerritsen WR; Westdorp H
    J Immunother; 2021 Sep; 44(7):276-282. PubMed ID: 33758147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nivolumab-Induced Guillain-Barré Syndrome Coupled With Remarkable Disease Response in a Case of Heavily Pretreated Lung Adenocarcinoma.
    Mazzaschi G; Bordi P; Fioretzaki R; Gnetti L; Milanese G; Tommasi C; Bersanelli M; Roti G; Scoditti U; Leonardi F; Quaini F; Tiseo M
    Clin Lung Cancer; 2020 Mar; 21(2):e65-e73. PubMed ID: 31837925
    [No Abstract]   [Full Text] [Related]  

  • 5. Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
    Tanaka R; Maruyama H; Tomidokoro Y; Yanagiha K; Hirabayashi T; Ishii A; Okune M; Inoue S; Sekine I; Tamaoka A; Fujimoto M
    Jpn J Clin Oncol; 2016 Sep; 46(9):875-8. PubMed ID: 27380808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Relapse of Vaccine-Induced Guillain-Barré Syndrome After Treatment With Nivolumab.
    Yuen C; Kamson D; Soliven B; Kramer C; Goldenberg F; Rezania K
    J Clin Neuromuscul Dis; 2019 Jun; 20(4):194-199. PubMed ID: 31135622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of severe pharyngeal-cervical-brachial syndrome induced by nivolumab and responding to infliximab therapy.
    Indini A; Sessa M; Merelli B; Foresti C; Mandalà M
    Eur J Cancer; 2020 Apr; 129():1-3. PubMed ID: 32092585
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute demyelinating polyneuropathy induced by nivolumab.
    Fukumoto Y; Kuwahara M; Kawai S; Nakahama K; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):435-437. PubMed ID: 28844069
    [No Abstract]   [Full Text] [Related]  

  • 9. Guillain-Barré syndrome in a patient with renal cell carcinoma following the first course of pazopanib therapy.
    Koshikawa H; Tsukie T; Kurita A; Fujikura M; Suzuki M; Araki K
    J Infect Chemother; 2017 Nov; 23(11):798-799. PubMed ID: 28506529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous Guillain-Barré syndrome and acute disseminated encephalomyelitis in the pediatric population.
    Bernard G; Riou E; Rosenblatt B; Dilenge ME; Poulin C
    J Child Neurol; 2008 Jul; 23(7):752-7. PubMed ID: 18354151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-existent ulcerative colitis and Guillain-Barré syndrome: a case report and literature review.
    Tominaga K; Tsuchiya A; Sato H; Kimura A; Oda C; Hosaka K; Kawata Y; Kimura N; Hayashi K; Yokoyama J; Terai S
    Clin J Gastroenterol; 2019 Jun; 12(3):243-246. PubMed ID: 30778832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated adrenocorticotropic hormone (ACTH) deficiency and Guillain-Barré syndrome occurring in a patient treated with nivolumab.
    Pierrard J; Petit B; Lejeune S; Seront E
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31439558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré syndrome after rituximab in a patient with idiopathic thombocytopenic purpura: a causal association?
    Jaso R; Sierra M; Calleja J; Valero C; Pascual J
    J Neurol; 2010 Mar; 257(3):488-9. PubMed ID: 20229293
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
    Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K
    Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome after allogeneic hematopoietic stem cell transplantation.
    Rodriguez V; Kuehnle I; Heslop HE; Khan S; Krance RA
    Bone Marrow Transplant; 2002 Mar; 29(6):515-7. PubMed ID: 11960272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guillain-Barre syndrome as a complication of epidural anaesthesia].
    Flores-Barragán JM; Martínez-Palomeque G; Ibáñez R; Castro-Ortiz A; Vaamonde-Gamo J
    Rev Neurol; 2006 May 16-31; 42(10):631-2. PubMed ID: 16703530
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome.
    Korinthenberg R
    Eur J Paediatr Neurol; 1998; 2(1):57-9. PubMed ID: 10726847
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel therapeutic approaches to Guillain-Barré syndrome.
    Pritchard J
    Expert Opin Investig Drugs; 2000 Oct; 9(10):2307-18. PubMed ID: 11060808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré syndrome following chickenpox: a case series.
    Tatarelli P; Garnero M; Del Bono V; Camera M; Schenone A; Grandis M; Benedetti L; Viscoli C
    Int J Neurosci; 2016; 126(5):478-9. PubMed ID: 26000930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome after combined CHOP and rituximab therapy in non-Hodgkin lymphoma.
    Terenghi F; Ardolino G; Nobile-Orazio E
    J Peripher Nerv Syst; 2007 Jun; 12(2):142-3. PubMed ID: 17565540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.